Profusa (PFSA) Cash from Operations (2022 - 2026)
Profusa posted quarterly Cash from Operations of 2600000.0 for Q1 2026, down 384.17% year-on-year from 914941.02 in Q1 2025, and up 49.31% on a QoQ basis from 5129000.0 in Q4 2025.
Profusa (PFSA) has 5 years of Cash from Operations data on file, last reported at 2600000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 384.17% year-over-year to 2600000.0; the trailing twelve-month figure through Mar 2026 stood at 18311000.0 (down 688.54% YoY), and the FY2025 full-year result was 16248000.0, down 686.45% from the prior year.
- Cash from Operations for Q1 2026 stood at 2600000.0, up from 5129000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 35386.0 in Q2 2025 and bottomed at 10617386.0 in Q3 2025.
- The 5-year median for Cash from Operations is 345210.0 (2023), against an average of 1385885.24.
- Peak annual rise in Cash from Operations reached 108.96% in 2025, while the deepest fall reached 2055.04% in 2025.
- A 5-year view of Cash from Operations shows it stood at 179348.0 in 2022, then tumbled by 92.48% to 345210.0 in 2023, then soared by 31.06% to 238000.0 in 2024, then slumped by 2055.04% to 5129000.0 in 2025, then soared by 49.31% to 2600000.0 in 2026.
- The last three Cash from Operations figures came in at 2600000.0 (Q1 2026), 5129000.0 (Q4 2025), and 10617386.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.74 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 220.10 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 525.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 335.40 Mn |
| 10 | Profusa | 574,294.01 | 574,294.01 | - | -2.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.60 Mn |
| Mar 31, 2026 | -2.60 Mn |
| Dec 31, 2025 | -5.13 Mn |
| Dec 31, 2025 | -5.13 Mn |
| Sep 30, 2025 | -10.62 Mn |
| Sep 30, 2025 | -10.62 Mn |
| Jun 30, 2025 | -139,173.00 |
| Jun 30, 2025 | -139,173.00 |
| Mar 31, 2025 | -362,441.00 |
| Mar 31, 2025 | -362,441.00 |
| Dec 31, 2024 | -238,000.00 |
| Dec 31, 2024 | -238,000.00 |
| Sep 30, 2024 | -1.15 Mn |
| Sep 30, 2024 | -1.15 Mn |
| Jun 30, 2024 | -394,878.00 |
| Jun 30, 2024 | -394,878.00 |
| Mar 31, 2024 | -280,853.00 |
| Mar 31, 2024 | -280,853.00 |
| Dec 31, 2023 | -345,210.00 |
| Dec 31, 2023 | -345,210.00 |
| Sep 30, 2023 | -479,775.00 |
| Sep 30, 2023 | -479,775.00 |
| Jun 30, 2023 | -273,268.00 |
| Jun 30, 2023 | -273,268.00 |
| Mar 31, 2023 | -966,607.00 |
| Mar 31, 2023 | -966,607.00 |
| Dec 31, 2022 | -179,348.00 |
| Dec 31, 2022 | -179,348.00 |
| Sep 30, 2022 | -107,855.00 |
| Sep 30, 2022 | -107,855.00 |
| Jun 30, 2022 | -63,634.00 |
| Jun 30, 2022 | -63,634.00 |
| Mar 31, 2022 | -230,352.00 |
| Mar 31, 2022 | -230,352.00 |